The Biotechnology Science Coordinating Committee (BSCC), at the behest of the White House Office of Science and Technology Policy (OSTP), held the first of three...


The federal regulatory policy in use today for biotechnology products, known as the Coordinated Framework for the Regulation of Biotechnology, was created in 1986 through a...


The Human Gene-Editing Initiative launched earlier this year by the National Academy of Science and the National Academy of Medicine held a public meeting to...


A new report from the National Academies of Sciences, Engineering, and Medicine concludes that the continuing growth of federal research regulations and requirements is "diminishing...


While the science behind the synthetic yeast genome project is cutting edge, the ethical questions surrounding it aren’t new. The scientists of the Sc2.0 project...


The use of fetal tissue has drawn increasing public scrutiny in recent weeks as a result of secret video recordings involving the Planned Parenthood Federation...


GSA has responded to a request for information from NIH's National Institute of General Medical Sciences on "Innovative Approaches to Technology Development for the Biomedical...


Long-time GSA member and former Drosophila Board President Denise Montell gave a briefing on Capitol Hill to discuss her research on "Life, Death, and Resurrection at...


Scientific progress runs on the intellect, curiosity, and passion of its practitioners fueled by the research dollars of its sponsors. The concern over research funding...


The directors of the White House Office of Management and Budget (OMB) and Office of Science and Technology Policy (OSTP) have distributed their annual memorandum...